Search This Blog

Thursday, February 9, 2023

Regeneron: Eylea OKd for Retinopathy of Prematurity

 ROP is a leading cause of childhood blindness worldwide

EYLEA now approved to treat five retinal conditions caused by ocular angiogenesis

https://finance.yahoo.com/news/eylea-aflibercept-injection-approved-first-234500750.html

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.